December 7, 2023, President Biden announced new actions to promote competition in health care and to lower prescription drug costs. Of particular note is a newly unveiled framework for deciding whether the Government may...more
12/11/2023
/ Biden Administration ,
Competition ,
Draft Guidance ,
Drug Pricing ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
March-in-Rights ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
PHRMA ,
Prescription Drugs ,
Proposed Regulation ,
Technology